Merck KGaA, Haleon warn of more inflation challenges in 2023

Merck KGaA, Haleon warn of more inflation challenges in 2023

Source: 
Fierce Pharma
snippet: 

For Darmstadt, Germany’s Merck KGaA, 2023 is shaping up to be another “challenging year,” thanks to a lull in the semiconductor market, decreased demand for COVID-related services and “persistently high inflation,” the company said in its latest earnings report.